Safety and Efficacy of Risankizumab in the Treatment of Chronic Plaque-Type Psoriasis: A Pilot Single-Arm, Single-Center, Prospective Cohort Study. Bang. Armed Forces Med. J. 2025;58(1):22-29. doi:10.3329/bafmj.v58i1.84958